These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 8984482)

  • 21. [Results of treatment in patients with destructive pulmonary tuberculosis without consideration of drug sensitivity in Mycobacterium tuberculosis].
    Abashev IM; Kozlova AI; Ivanova LN
    Probl Tuberk Bolezn Legk; 2008; (1):33-5. PubMed ID: 18318228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of treatment for pulmonary tuberculosis with multidrug mycobacterial resistance].
    Mishin VIu; Chukanov VI; Vasil'eva IA
    Probl Tuberk; 2002; (12):18-23. PubMed ID: 12611329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
    Muratov VV; Pashkov IuN; Pospelov VV
    Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
    [No Abstract]   [Full Text] [Related]  

  • 26. [Complex treatment of destructive pulmonary tuberculosis].
    Shul'ga IA; Znosenko VA; Sukhorukova IS; Davydova GN; Surovtseva EIa; Shlapakova MA; Pelipas IG
    Probl Tuberk Bolezn Legk; 2003; (7):29-31. PubMed ID: 12939873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the morphological diagnosis of drug-resistant pulmonary tuberculosis].
    Ziuzia IuR; Lepekha LN; Gedymin LE; Burtseva SA; Erokhin VV
    Probl Tuberk Bolezn Legk; 2006; (10):56-60. PubMed ID: 17139834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The nature of bacterial shedding and its effect on treatment outcome in newly detected patients with destructive pulmonary tuberculosis].
    Omarov TO; Krivtsova AE; Kumisbaeva BT
    Probl Tuberk; 1988; (8):19-20. PubMed ID: 2974156
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pathogenetic drugs in the treatment of destructive pulmonary tuberculosis in adolescents and adults].
    Buĭko RG; Maksimova NM
    Probl Tuberk; 1984 Jan; (1):45-9. PubMed ID: 6422459
    [No Abstract]   [Full Text] [Related]  

  • 30. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
    Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
    Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficiency of the use of peppermint (Mentha piperita L) essential oil inhalations in the combined multi-drug therapy for pulmonary tuberculosis].
    Shkurupiĭ VA; Kazarinova NV; Ogirenko AP; Nikonov SD; Tkachev AV; Tkachenko KG
    Probl Tuberk; 2002; (4):36-9. PubMed ID: 12125251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
    J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Infiltrative pulmonary tuberculosis: course and efficiency of treatment].
    Mishin VIu; Nazarova NV; Kononen AS; Miakishev TV; Sadovski AI
    Probl Tuberk Bolezn Legk; 2006; (10):7-12. PubMed ID: 17139824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Belianin II; Shmelev EI
    Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Individual approaches to complex treatment of disseminated tuberculous processes in adolescents].
    Gergert VIa; Rusakova LI
    Probl Tuberk Bolezn Legk; 2006; (8):33-7. PubMed ID: 17002056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical picture and treatment of fibrocavernous tuberculosis of the lungs complicated by nonspecific infection].
    Ianovskaia LM; Murakhovskaia SG; Kaliuk LN
    Klin Med (Mosk); 1973 Mar; 51(3):76-9. PubMed ID: 4201985
    [No Abstract]   [Full Text] [Related]  

  • 37. [Etiopathogenesis, clinical picture and treatment of progressive forms of pulmonary tuberculosis].
    Suslov VA
    Voen Med Zh; 1996 Jul; 317(7):29-34, 80. PubMed ID: 8967037
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative characteristics of disseminated pulmonary tuberculosis in patients isolating Mycobacterium tuberculosis with a high and low viability].
    Koretskaia NM; Iarygina IV
    Probl Tuberk Bolezn Legk; 2007; (2):17-20. PubMed ID: 17419328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rapidly progressing forms of pulmonary tuberculosis in adolescents].
    Rusakova LI
    Probl Tuberk; 2001; (1):31-4. PubMed ID: 11337778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Specific features of diagnosis and treatment of patients with pulmonary sarcoidosis and tuberculosis].
    Kostina ZI; Brazhenko NA; Gerasimova EV; Kol'nikova OV
    Probl Tuberk; 1998; (2):10-3. PubMed ID: 9613175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.